Monitoring of radical scavenging activity of peroral administration of the Kampo medicine Sho-saiko-to in rats

被引:14
作者
Egashira, T
Takayama, F
Yamanaka, Y
Komatsu, Y
机构
[1] Oita Med Univ, Dept Pharmacol, Oita 8795593, Japan
[2] Tsumura & Co, Kampo & Pharmacognosy Labs, Ami, Ibaragi 3001192, Japan
关键词
Sho-saiko-to (Kampo medicine); radical scavenger; pharmacodynamics;
D O I
10.1254/jjp.80.379
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Kampo medicine Sho-saiko-to scavenged superoxide anion radicals (O-2(-)), hydroxyl radicals ( OH) and 1,1 -diphenyl-2-picrylhydrazyl (DPPH) radicals in a dose-dependent fashion. We attempted to investigate the transition of free radical scavenging activity in plasma after oral administration of Sho-saiko-to in rats. From the response-time profile, kinetic parameters including values for K-a (absorption rate constant), T-max (peak concentration time), T-1/2 (half life) and MRT (mean residence time) of radical scavenging activity in plasma could be calculated for the O-2(-), .OH and DPPH radicals. These parameters calculated from the dynamics of antioxidation are considered a very meaningful procedure to examine the effects of Sho-saiko-to.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 14 条
[1]  
AMAGAYA S, 1984, J PHARMACOBIO-DYNAM, V7, P923
[2]  
HATANO T, 1989, CHEM PHARM BULL, V37, P2016
[3]   HYDROXYL RADICAL SCAVENGING ACTIVITY OF FLAVONOIDS [J].
HUSAIN, SR ;
CILLARD, J ;
CILLARD, P .
PHYTOCHEMISTRY, 1987, 26 (09) :2489-2491
[4]  
KUBO M, 1984, CHEM PHARM BULL, V32, P2724
[5]   THE ANTIOXIDANTS OF HIGHER-PLANTS [J].
LARSON, RA .
PHYTOCHEMISTRY, 1988, 27 (04) :969-978
[6]   PROTECTIVE EFFECT OF QUERCETIN AND RUTIN ON PHOTOSENSITIZED LYSIS OF HUMAN-ERYTHROCYTES IN THE PRESENCE OF HEMATOPORPHYRIN [J].
SORATA, Y ;
TAKAHAMA, U ;
KIMURA, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 799 (03) :313-317
[7]   EFFECT OF DICLOFENAC, A NONSTEROIDAL ANTIINFLAMMATORY DRUG, ON LIPID-PEROXIDATION CAUSED BY ISCHEMIA-REPERFUSION IN RAT-LIVER [J].
TAKAYAMA, F ;
EGASHIRA, T ;
YAMANAKA, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 64 (02) :71-78
[8]  
TASHIRO S, 1997, METHODS KAMPO PHARM, V1, P39
[9]  
UCHIDA E, 1995, JPN PHARMACOL THER, V23, P659
[10]  
UEDA Y, 1995, NEUROSCIENCES-JPN, V21, P75